Mepolizumab
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2059 publications
Pulmonology: What You May Have Missed in 2025.
Journal: Annals of internal medicine
Published: April 13, 2026
High Response Rates and Predictors in Patients with CRSwNP Treated With Mepolizumab and Dupilumab: Results From a Prospective, Multicenter Cohort Study.
Journal: American journal of rhinology & allergy
Published: April 06, 2026
Control Status of Chronic Rhinosinusitis in Severe Asthma Patients Receiving Biologics: A Real-World Cross-Sectional Study.
Journal: The Annals of otology, rhinology, and laryngology
Published: April 02, 2026
Acute Single Subcortical Infarction and Atypical Purpura in Eosinophilic Granulomatosis with Polyangiitis: A Case Report.
Journal: Journal of investigational allergology & clinical immunology
Published: March 27, 2026
Dual clinical remission in severe asthma and chronic rhinosinusitis with nasal polyps: a comparative review of biologic therapies.
Journal: Expert opinion on biological therapy
Published: March 24, 2026
Functional response, in T2 severe asthmatic patients, treated with mepolizumab for 2 years.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: March 21, 2026
Response to the Letter to the Editor by Pirola and Hopkins Regarding "the Global Airways in Practice: Long-Term Effects of Mepolizumab with or without FESS on Type 2 Inflammation in Patients with CRSwNP".
Journal: International forum of allergy & rhinology
Published: March 19, 2026
Successful early use of mepolizumab in eosinophilic granulomatosis with polyangiitis presenting with peripheral neuropathy and gastrointestinal bleeding
Journal: Rinsho shinkeigaku = Clinical neurology
Published: March 15, 2026
Efficacy and safety of biologics in children and adolescents with eosinophilic asthma: A systematic review and meta-Analysis.
Journal: Asian Pacific journal of allergy and immunology
Published: March 15, 2026
Baseline dual elevation of fractional exhaled nitric oxide and blood eosinophils is associated with clinical remission in severe eosinophilic asthma treated with biologics: a real-world prospective study.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: March 14, 2026
Biologics in severe asthma: from precision phenotyping to clinical remission.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: March 14, 2026
On the Interpretation of Long-Term Outcomes After Combined FESS and Mepolizumab in Severe CRSwNP.
Journal: International forum of allergy & rhinology
Published: March 09, 2026
Last Updated: 04/28/2026